GeneCopoeia ACE2 and lung stable cell lines for COVID-19 research

Thursday, 28 May, 2020 | Supplied by: United Bioresearch Products Pty Ltd

GeneCopoeia offers collections of cell lines expressing human host factors needed for SARS-CoV-2 infection as well as labelled cancer cell lines, which include five lung cancer cell line derivatives.

Angiotensin-converting enzyme 2 (ACE2) has been identified as a functional receptor for SARS-CoV1 and a potent receptor for 2019-nCoV2. ACE2 is a carboxypeptidase that potently degrades angiotensin II to angiotensin 1–7, playing a key role in the renin-angiotensin system (RAS). GeneCopoeia carries a HEK293T cell line expressing ACE2, the receptor needed for SARS-CoV-2 infection in humans.

In addition to the ACE2 stable cell line, the company also offers lung cancer cell lines, which contain both firefly luciferase and GFP or GFP alone, integrated into the genome. These are valuable for COVID-19 coronavirus research since the SARS-CoV-2 virus enters the body via lung epithelial cells, and can be used for drug target identification and compound screening either in vitro or in vivo.

Phone: 02 4575 0309
Related Products

Cayman Chemical Total Iron-Binding Capacity (TIBC) and Serum Iron Assay Kit

Cayman Chemical's Total Iron-Binding Capacity (TIBC) and Serum Iron Assay Kit provides a...

Sphere Fluidics Cyto-Mine single-cell analysis system for cell line development

Sphere Fluidics' Cyto-Mine is a single-cell analysis platform that enables individual cells...

Bio-Rad Laboratories CFX Opus Deepwell Real-Time PCR Detection System

Bio-Rad Laboratories has launched the CFX Opus Deepwell Real-Time PCR Detection System to support...

  • All content Copyright © 2022 Westwick-Farrow Pty Ltd